Follow up Approaches in Thyroid Cancer: A Risk Adapted Paradigm

Ries

Hay, 2002, Papillary thyroid carcinoma managed at the Mayo clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients, World J Surg, 26, 879, 10.1007/s00268-002-6612-1

Mazzaferri, 2001, Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer, J Clin Endocrinol Metab, 86, 1447, 10.1210/jc.86.4.1447

Hundahl, 2000, Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German thyroid cancer study group. An American college of surgeons commission on cancer patient care evaluation study, Cancer, 89, 202, 10.1002/1097-0142(20000701)89:1<202::AID-CNCR27>3.0.CO;2-A

Ries

Bta

Cooper, 2006, Management guidelines for patients with thyroid nodules and differentiated thyroid cancer, Thyroid, 16, 109, 10.1089/thy.2006.16.109

Pacini, 2006, European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium, Eur J Endocrinol, 154, 787, 10.1530/eje.1.02158

Sherman

Thyroid Carcinoma Task Force, 2001, AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American association of clinical endocrinologists. American college of endocrinology, Endocr Pract, 7, 202, 10.4158/EP.7.3.202

Watkinson, 2004, The British thyroid association guidelines for the management of thyroid cancer in adults, Nucl Med Commun, 25, 897, 10.1097/00006231-200409000-00006

Tuttle, 2007, Papillary thyroid cancer: monitoring and therapy, Endocrinol Metab Clin North Am, 36, 753, 10.1016/j.ecl.2007.04.004

Grebe, 1996, Thyroid cancer nodal metastases: biologic significance and therapeutic considerations, Surg Oncol Clin N Am, 5, 43, 10.1016/S1055-3207(18)30404-6

2002

Dean, 2000, Prognostic indicators in differentiated thyroid carcinoma, Cancer Control, 7, 229, 10.1177/107327480000700302

Pacini, 2001, Outcome of differentiated thyroid cancer with detectable serum Tg and negative diagnostic (131)I whole body scan: comparison of patients treated with high (131)I activities versus untreated patients, J Clin Endocrinol Metab, 86, 4092, 10.1210/jc.86.9.4092

Pacini, 2003, Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma, J Clin Endocrinol Metab, 88, 3668, 10.1210/jc.2002-021925

Robbins, 2006, Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning, J Clin Endocrinol Metab, 91, 498, 10.1210/jc.2005-1534

Wang, 2001, Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine, Thyroid, 11, 1169, 10.1089/10507250152741028

Shaha, 1997, Low-risk differentiated thyroid cancer: the need for selective treatment, Ann Surg Oncol, 4, 328, 10.1007/BF02303583